Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.
复制标题

DOI:
10.18632/oncotarget.3402
复制
发表时间:
2015-04-30
期刊:
影响因子:
--
通讯作者:
Aneja R
Aneja R
中科院分区:
其他
文献类型:
--
作者:
Pannu V;Mittal K;Cantuaria G;Reid MD;Li X;Donthamsetty S;McBride M;Klimov S;Osan R;Gupta MV;Rida PC;Aneja R

文献摘要

参考文献

相似文献

Centrosome amplification (CA), a cell-biological trait, characterizes pre-neoplastic and pre-invasive lesions and is associated with tumor aggressiveness. Recent studies suggest that CA leads to malignant transformation and promotes invasion in mammary epithelial cells. Triple negative breast cancer (TNBC), a histologically-aggressive subtype shows high recurrence, metastases, and mortality rates. Since TNBC and non-TNBC follow variable kinetics of metastatic progression, they constitute a novel test bed to explore if severity and nature of CA can distinguish them apart. We quantitatively assessed structural and numerical centrosomal aberrations for each patient sample in a large-cohort of grade-matched TNBC (n = 30) and non-TNBC (n = 98) cases employing multi-color confocal imaging. Our data establish differences in incidence and severity of CA between TNBC and non-TNBC cell lines and clinical specimens. We found strong correlation between CA and aggressiveness markers associated with metastasis in 20 pairs of grade-matched TNBC and non-TNBC specimens (p < 0.02). Time-lapse imaging of MDA-MB-231 cells harboring amplified centrosomes demonstrated enhanced migratory ability. Our study bridges a vital knowledge gap by pinpointing that CA underlies breast cancer aggressiveness. This previously unrecognized organellar inequality at the centrosome level may allow early-risk prediction and explain higher tumor aggressiveness and mortality rates in TNBC patients.
DOI: 10.1186/bcr76
发表时间: 2000
期刊: Breast cancer research : BCR
影响因子: --
作者:
通讯作者: --
DOI: 10.1073/pnas.95.6.2950
发表时间: 1998-03-17
影响因子: 11.1
作者:
Lingle, WL;Lutz, WH;Salisbury, JL
通讯作者: Salisbury, JL
DOI: 10.1016/s0165-4608(00)00384-8
发表时间: 2001-04-01
影响因子: --
作者:
Sato, N;Mizumoto, K;Tanaka, M
通讯作者: Tanaka, M
伯基特淋巴瘤中没有持续的数值染色体不稳定性,过度的中心体异常。
DOI: 10.1186/1476-4598-2-30
发表时间: 2003-09-08
期刊: MOLECULAR CANCER
影响因子: 37.3
作者:
Duensing, Stefan;Lee, Benjamin H;Dal Cin, Paola;Munger, Karl
通讯作者: Munger, Karl
DOI: 10.1186/1471-2407-14-645
发表时间: 2014-09-01
期刊: BMC cancer
影响因子: 3.8
作者:
Seong MW;Cho SI;Kim KH;Chung IY;Kang E;Lee JW;Park SK;Lee MH;Choi DH;Yom CK;Noh WC;Chang MC;Park SS;Kim SW;Korean Hereditary Breast Cancer Study Group
通讯作者: Korean Hereditary Breast Cancer Study Group